Expression of matrix metalloproteinase-26 in multiple human cancer tissues and smooth muscle cells

Chinese Journal of Cancer

Volumn 28, Issue 11, 2009, Pages 44-49

  Zhao, Yun Ge ^a   Xiao, Ai Zhen ^a   Ni, Jian ^b   Man, Yan Gao ^c   Sang, Qing Xiang Amy ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b Human Antibodomics (SIP)Inc   (China)

^c ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Human neoplasms; Integrated morphometry analysis; Matrix metalloproteinase 26; Smooth muscle cell; Tissue microarray

Indexed keywords

MATRIX METALLOPROTEINASE 26; MESSENGER RNA; MOLECULAR MARKER;

ARTERY MUSCLE; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER TISSUE; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CORONARY ARTERY; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; LUNG CANCER; MELANOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; RECTUM CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STOMACH CANCER; THYROID CANCER; TISSUE MICROARRAY;

EID: 77950923955     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.008.10768     Document Type: Article

References (19)

1. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis [J]. J Natl Cancer Inst, 1997,89(17): 1260-1270.
2. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications [J]. J Clin Oncol, 2000,18(5): 1135-1149.
3. Park HI, Ni J, Gerkema FE, et al. Identification and characterization of human endometase (matrix metalloproteinase-26) from endometrial tumor [J]. J Biol Chem, 2000,275(27):20540-20544.
4. de Coignac AB, Elson G, Delneste Y, et al. Cloning of MMP-26. A novel matrilysin-like proteinase [J]. Eur J Biochem, 2000,267(11):3323-3329.
5. Una JA, Lopez-Otin C. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity [J]. Cancer Res, 2000,60(17):4745-4751.
6. Marchenko GN, Ratnikov BI, Rozanov DV, et al. Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin [J]. Biochem J, 2001,356 (Pt 3):705-718.
7. Park HI, Turk BE, Gerkema FE, et al. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26 [J]. J Biol Chem, 2002,277(38):35168-35175.
8. Zhao YG, Xiao AZ, Newcomer RG, et al. Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells [J]. J Biol Chem, 2003,278(17):15056-15064.
9. Marchenko GN, Marchenko ND, Leng J, et al. Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin [J]. Biochem J, 2002,363(Pt 2):253-262.
10. Zhang J, Cao YJ, Zhao YG, et al. Metalloproteinase-26 (MMP-26) and tissue inhibitor of metalloproteinase-4 (TIMP-4) in human normal cytotrophoblast cells and a choriocarcinoma cell line JEG-3 [J]. Mol Human Reprod, 2002,8(7):659-666.
11. Lee S, Desai KK, Iczkowski KA, et al. Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor [J]. Cell Res. 2006,16(9):750-758.
12. Zhao YG, Xiao AZ, Park HI, et al. Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion [J]. Cancer Res, 2004,64(2):590-598.
13. Ripley D, Tunuguntla R, Susi L, et al. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinase-3 and -4 in normal ovary and ovarian carcinoma [J]. Int J Gynecol Cancer, 2006,16 (5):1794-800.
14. Celentano DC, Frishman WH. Matrix metalloproteinases and coronary artery disease: a novel therapeutic target [J]. J Clin Pharmacol, 1997, 37 (11): 991-1000.
15. Pauly RR, Passaniti A, Bilato C, et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation [J]. Circ Res, 1994, 75(1):41-54.
16. Mason DP, Kenagy RD, Hasenstab D, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery [J]. Circ Res, 1999, 85 (12): 1179-1185.
17. Moon SK, Cha BY, Kim CH. In vitro cellular aging is associated with enhanced proliferative capacity, G1 cell cycle modulation, and matrix metalloproteinase-9 regulation in mouse aortic smooth muscle cells [J]. Arch Biochem Biophys, 2003,418(1):39-48.
18. Johnson C, Galis ZS. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization [J]. Arterioscler Thromb Vasc Biol, 2004,24(1):54-60.
19. Kato S, Yasukawa H, Fujii T, et al. Coordinate regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 expression in human vascular smooth muscle cells [J]. Connect Tissue Res, 2000,41 (2):143-153.